Target intelligence / Profile preview

RNA, U4 small nuclear 1 (RNU4-1)

Target
RNU4-1
Molecular classification
Small nuclear RNA (snRNA), Non-coding RNA, Component of spliceosome, U4/U6 small nuclear ribonucleoprotein particle
01

Overview

RNA, U4 small nuclear 1 (RNU4-1) is a noncoding small nuclear RNA (snRNA) that plays a critical role as a structural and functional component of the major spliceosome, the molecular machinery responsible for the removal of introns from pre-mRNA. RNU4-1 is required for the assembly of the tri-snRNP complex (U4/U6.U5), in which it forms a duplex with U6 snRNA and participates in regulating the splicing cycle. It enables U6 snRNA binding and helps maintain proper spliceosome assembly and splicing fidelity. Variants in closely related U4 snRNA genes (such as RNU4-2) are known to cause neurodevelopmental disorders, underlining the critical nature of the U4 family's splicing functions. RNU4-1 itself has been implicated in the differential regulation of alternative splicing events and has been associated with prognosis in several cancers, though it is not currently a therapeutic target. It is classified as a small nuclear RNA and not a receptor, enzyme, transporter, or traditional "drug target" in molecular medicine[1][2][3][4][6].

Other names
RNU4ARNU4B2U4U4BLRNA, U4A small nuclearRNA, U4B2 small nuclearRNU4-1
02

Biological functions

Pre-mRNA splicingSpliceosomal tri-snRNP complex assemblyU6 snRNA binding
03

Disease associations

Neurodevelopmental disorders (notably associated with ReNU syndrome via close homolog RNU4-2)Endometrial cancer (as a prognostic marker)Colorectal adenocarcinoma (as a prognostic biomarker)
04

Safety considerations

No direct therapeutic safety concerns reported; not an established drug target
05

Biomarkers

Prognostic marker for colorectal adenocarcinoma and endometrial cancer (not as a direct therapeutic biomarker, but as part of survival signatures)

Beyond the preview

Go deeper on RNA, U4 small nuclear 1 (RNU4-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 1 (RNU4-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call